Candel Therapeutics

The stock market experienced a wave of optimism on Wednesday, driven by the latest inflation report. The Nasdaq 100 surged 1.7%, achieving a new record high, while the S&P 500 climbed 0.8%. This bullish sentiment was fueled by expectations of a 25-basis-point rate cut at the upcoming Federal...

The U.S. stock market experienced a downturn on Thursday, with the Dow Jones index falling by 1.35% to 38,596.98. The NASDAQ and the S&P 500 also dipped, falling 1.4% to 16,049.08 and 1.23% to 5,147.21 respectively. Despite the overall market decline, certain stocks managed to capture the...

A clinical-stage biopharmaceutical company looks forward to the year ahead with several promising developments in motion.  Focused on the development of multimodal biological immunotherapies to help patients fight cancer, Candel Therapeutics, Inc. (NASDAQ: CADL) is innovating a new frontier in...